^
Phase 2
National Cancer Institute (NCI)
Completed
Last update posted :
07/30/2019
Initiation :
03/21/2011
Primary completion :
08/20/2016
Completion :
11/03/2016
MUC16
|
Avastin (bevacizumab) • cisplatin • Beianting (bevacizumab biosimilar) • Boyounuo (bevacizumab biosimilar) • Hanbeitai (bevacizumab biosimilar) • Vasforda (bevacizumab biosimilar) • Zybrestat (fosbretabulin)
Phase 2
Mateon Therapeutics
Completed
Last update posted :
12/05/2017
Initiation :
09/01/2014
Primary completion :
06/01/2016
Completion :
08/01/2016
CHGA
|
Zybrestat (fosbretabulin)